3B BlackBio Dx Subsidiary Coris Acquires Facility Owner Bilex SRL
3B BlackBio Dx Ltd · Others (Uncategorized) · 18 Nov 2026, 10:55 pm
3B BlackBio Dx Subsidiary Coris Acquires Facility Owner Bilex SRL 3B BlackBio Dx Ltd.'s subsidiary, Coris Bioconcept SRL, entered into an agreement on 18th Nov'26 to acquire 100% of Bilex SRL, owner of Coris's operating land and manufacturing facility in Gembloux, Belgium. Coris transitions from tenant to owner-occupier for a cash consideration of €274,817, alongside repaying €1.32 million in unsecured shareholder loans and continuing €2.11 million in long-term building loans at 1.3% average interest. The transaction eliminates intercompany rental outgo, generating immediate net annual savings of €140,000 before depreciation.
Original exchange filing (PDF)
More announcements from 3B BlackBio Dx Ltd
- Analyst/Investor Meet intimation · 16 Nov 2026
- Financial Results for the quarter and half year ended 30th September, 2026 · 13 Nov 2026
- Financial Results for the quarter and half year ended 30th September, 2026 · 13 Nov 2026
- Investor Presentation · 13 Nov 2026
- Financial Results for the quarter and half-year ended 30th September, 2026 · 13 Nov 2026
- Outcome of Board Meeting · 13 Nov 2026
- 3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve the Unaudited Standalone and .... · 13 Nov 2026
- Re-appointment of director who retires by rotation and being eligible, offers for re-appointment · 30 Sept 2026
